Showing results (11-20 of 82) with videos related to
Sort By:
Pageof 9
Expert Opinion on Pharmacotherapy|March 26, 2013
Hyperparathyroidism in chronic kidney disease patients: an update on current pharmacotherapyMasafumi Fukagawa, Hirotaka Komaba, Takatoshi KakutaClinical and Experimental Nephrology|August 6, 2011
Diseases of the parathyroid gland in chronic kidney diseaseHirotaka Komaba, Takatoshi Kakuta, Masafumi FukagawaTherapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 21, 2011
Parathyroid hormone control survey to determine inter-method and inter-lab variations in JapanTakatoshi Kakuta, Hitoshi Kato, Hirotaka Komaba, et al.NDT Plus|May 19, 2015
Indication and efficacy of PEIT in the management of secondary hyperparathyroidismFumihiko Koiwa, Takeshi Hasegawa, Reika Tanaka, et al.Clinical and Experimental Nephrology|May 2, 2015
Mineral and bone disorders in kidney transplant recipients: reversible, irreversible, and de novo abnormalitiesTakashi Hirukawa, Takatoshi Kakuta, Michio Nakamura, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 28, 2006
Efficacy of percutaneous ethanol injection therapy (PEIT) is related to the number of parathyroid glands in haemodialysis patients with secondary hyperparathyroidismFumihiko Koiwa, Takatoshi Kakuta, Reika Tanaka, et al.The Tokai Journal of Experimental and Clinical Medicine|September 16, 2016
A Case of Encapsulating Peritoneal Sclerosis Complicated by Malignant Peritoneal MesotheliomaGenta Kanai, Takatoshi Kakuta, Takashi Hirukawa, et al.Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|December 28, 2011
Role of uremic toxins and oxidative stress in the development of chronic kidney disease-mineral and bone disorderHisae Tanaka, Hirotaka Komaba, Masahiro Koizumi, et al.Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 21, 2011
Novel electrochemiluminescence immunoassay exclusively for full-length parathyroid hormone during treatment with cinacalcet for secondary hyperparathyroidismHisae Tanaka, Hirotaka Komaba, Masahiro Koizumi, et al.Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|October 13, 2018
A Retrospective Study on Erythropoiesis Stimulating Agent Dose Reducing Potential of an Anti-Platelet Activation Membrane Dialyzer in Hemodialysis PatientsTakatoshi Kakuta, Mari Ishida, Hirotaka Komaba, et al.Pageof 9